AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. SBET
  4. [8-K] SharpLink Gaming Ltd. Reports Material Event

[8-K] SharpLink Gaming Ltd. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

SunLink Health Systems, Inc. (NYSE American: SSY) filed an 8-K (Item 8.01) dated 24 Jul 2025 reporting the release of a press announcement tied to its pending merger with Regional Health Properties, Inc.

  • Record date: 20 Jun 2025; shareholders are urged to submit proxy votes no later than 28 Jun 2025, 11:59 p.m. EDT.
  • Regional has already filed a Form S-4 containing the joint proxy statement/prospectus, mailed on or about 30 Jun 2025.
  • The press release is furnished as Exhibit 99.1; an Inline XBRL cover file is provided as Exhibit 104.
  • The filing reiterates that it is not an offer to sell securities and directs investors to obtain free copies of the proxy materials via the SEC or company websites.

The remainder of the report consists of forward-looking-statement disclaimers outlining risks such as potential litigation, integration hurdles, listing-requirement compliance, and macroeconomic headwinds. No financial statements or operating results are included.

SunLink Health Systems, Inc. (NYSE American: SSY) ha presentato un 8-K (Voce 8.01) datato 24 luglio 2025, comunicando il rilascio di un annuncio stampa relativo alla sua fusione in corso con Regional Health Properties, Inc.

  • Data di registrazione: 20 giugno 2025; gli azionisti sono invitati a inviare i propri voti per delega entro e non oltre il 28 giugno 2025, ore 23:59 EDT.
  • Regional ha gi脿 presentato un Modulo S-4 contenente la dichiarazione congiunta per delega/prospetto, spedito intorno al 30 giugno 2025.
  • Il comunicato stampa 猫 fornito come Allegato 99.1; un file di copertura Inline XBRL 猫 disponibile come Allegato 104.
  • La comunicazione ribadisce che non si tratta di un'offerta di vendita di titoli e invita gli investitori a ottenere copie gratuite dei materiali per delega tramite i siti web della SEC o della societ脿.

Il resto del rapporto 猫 costituito da disclaimer sulle dichiarazioni previsionali che evidenziano rischi quali possibili contenziosi, difficolt脿 di integrazione, conformit脿 ai requisiti di quotazione e condizioni macroeconomiche avverse. Non sono inclusi bilanci n茅 risultati operativi.

SunLink Health Systems, Inc. (NYSE American: SSY) present贸 un 8-K (Art铆culo 8.01) fechado el 24 de julio de 2025, informando sobre la publicaci贸n de un comunicado de prensa relacionado con su fusi贸n pendiente con Regional Health Properties, Inc.

  • Fecha de registro: 20 de junio de 2025; se insta a los accionistas a enviar sus votos por poder a m谩s tardar el 28 de junio de 2025, 11:59 p.m. EDT.
  • Regional ya ha presentado un Formulario S-4 que contiene la declaraci贸n conjunta para poderes/prospecto, enviado alrededor del 30 de junio de 2025.
  • El comunicado de prensa se presenta como Exhibici贸n 99.1; un archivo de portada Inline XBRL se proporciona como Exhibici贸n 104.
  • La presentaci贸n reitera que no es una oferta para vender valores y dirige a los inversores a obtener copias gratuitas de los materiales de poder a trav茅s de los sitios web de la SEC o de la empresa.

El resto del informe consiste en disclaimers sobre declaraciones prospectivas que describen riesgos tales como posibles litigios, dificultades de integraci贸n, cumplimiento de requisitos de listado y vientos macroecon贸micos adversos. No se incluyen estados financieros ni resultados operativos.

SunLink Health Systems, Inc. (NYSE American: SSY)電� 2025雲� 7鞗� 24鞚检瀽 8-K (頃 8.01)毳� 鞝滌稖頃橃棳 Regional Health Properties, Inc.鞕�鞚� 歆勴枆 欷戩澑 頃╇硲瓿� 甏�霠悳 氤措弰鞛愲 氚滍憸毳� 氤搓碃頄堨姷雼堧嫟.

  • 旮半鞚�: 2025雲� 6鞗� 20鞚�; 欤检＜霌れ潃 電柎霃� 2025雲� 6鞗� 28鞚� 鞓ろ泟 11:59 EDT旯岇 雽�毽� 韴憸毳� 鞝滌稖頃� 瓴冹潉 甓岅碃氚涭晿鞀惦媹雼�.
  • Regional鞚� 鞚措 瓿惦彊 鞙勳瀯鞛�/靹る獏靹滉皜 韽暔霅� Form S-4毳� 鞝滌稖頄堨溂氅�, 鞚措姅 2025雲� 6鞗� 30鞚缄步 鞖绊幐 氚滌啞霅橃棃鞀惦媹雼�.
  • 氤措弰鞛愲电� Exhibit 99.1搿� 鞝滉车霅橂┌, 鞚鸽澕鞚� XBRL 旎る矂 韺岇澕鞚� Exhibit 104搿� 鞝滉车霅╇媹雼�.
  • 頃措嫻 鞝滌稖 靹滊電� 歃濌秾 韺愲Г 鞝滌晥鞚� 鞎勲嫎鞚� 鞛皑 氇呾嫓頃橂┌, 韴瀽鞛愲摛鞐愱矊 SEC 霕愲姅 須岇偓 鞗轨偓鞚错姼毳� 韱淀暣 鞙勳瀯鞛� 鞛愲毳� 氍措搿� 氚涭潉 瓴冹潉 鞎堧偞頃╇媹雼�.

氤搓碃靹滌潣 雮橂ǜ歆� 攵�攵勳潃 鞛犾灛鞝� 靻岇啞, 韱淀暕 氍胳牅, 靸侅灔 鞖旉贝 欷�靾�, 瓯办嫓瓴届牅 鞐拲 霌� 鞙勴棙鞚� 靹る獏頃橂姅 氙鸽灅 鞓堨浮 歆勳垹 氅挫眳 臁绊暛鞙茧 甑劚霅橃柎 鞛堨姷雼堧嫟. 鞛鞝滍憸雮� 鞖挫榿 瓴瓣臣電� 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟.

SunLink Health Systems, Inc. (NYSE American聽: SSY) a d茅pos茅 un 8-K (Article 8.01) dat茅 du 24 juillet 2025, annon莽ant la publication d'un communiqu茅 de presse li茅 脿 sa fusion en attente avec Regional Health Properties, Inc.

  • Date d'enregistrement聽: 20 juin 2025聽; les actionnaires sont invit茅s 脿 soumettre leurs votes par procuration au plus tard le 28 juin 2025, 23h59 EDT.
  • Regional a d茅j脿 d茅pos茅 un Formulaire S-4 contenant la d茅claration de procuration/prospectus conjoint, envoy茅 vers le 30 juin 2025.
  • Le communiqu茅 de presse est fourni en tant que Pi猫ce 99.1聽; un fichier de couverture Inline XBRL est fourni en pi猫ce 104.
  • Le d茅p么t r茅it猫re qu'il ne s'agit pas d'une offre de vente de titres et invite les investisseurs 脿 obtenir gratuitement les documents de procuration via les sites web de la SEC ou de la soci茅t茅.

Le reste du rapport comprend des clauses de non-responsabilit茅 relatives aux d茅clarations prospectives, exposant des risques tels que des litiges potentiels, des difficult茅s d'int茅gration, la conformit茅 aux exigences de cotation et des vents contraires macro茅conomiques. Aucun 茅tat financier ni r茅sultat op茅rationnel n'est inclus.

SunLink Health Systems, Inc. (NYSE American: SSY) reichte am 24. Juli 2025 ein 8-K (Punkt 8.01) ein, in dem die Ver枚ffentlichung einer Pressemitteilung im Zusammenhang mit der anh盲ngigen Fusion mit Regional Health Properties, Inc. gemeldet wurde.

  • Stichtag: 20. Juni 2025; Aktion盲re werden aufgefordert, ihre Stimmrechtsvollmachten sp盲testens bis zum 28. Juni 2025, 23:59 Uhr EDT einzureichen.
  • Regional hat bereits ein Formular S-4 eingereicht, das die gemeinsame Vollmachts-/Prospekterkl盲rung enth盲lt, die etwa am 30. Juni 2025 versandt wurde.
  • Die Pressemitteilung ist als Anlage 99.1 beigef眉gt; eine Inline-XBRL-Coverdatei ist als Anlage 104 verf眉gbar.
  • Die Einreichung betont, dass es sich nicht um ein Angebot zum Verkauf von Wertpapieren handelt und verweist Investoren darauf, kostenlose Kopien der Vollmachtsunterlagen 眉ber die SEC- oder Unternehmenswebsites zu beziehen.

Der Rest des Berichts besteht aus Haftungsausschl眉ssen zu zukunftsgerichteten Aussagen, die Risiken wie m枚gliche Rechtsstreitigkeiten, Integrationsprobleme, Einhaltung von B枚rsenzulassungsanforderungen und makro枚konomische Gegenwinde darlegen. Es sind keine Finanzberichte oder Betriebsergebnisse enthalten.

Positive
  • Shareholder vote scheduled for 28 Jun 2025 demonstrates the merger process is advancing on a defined timetable.
  • Form S-4 and joint proxy statement have already been mailed, showing regulatory filings are substantially complete.
Negative
  • Extensive risk disclosures emphasise litigation, integration, and listing-compliance uncertainties that could derail or delay the merger.
  • No new financial or synergy metrics were provided, leaving investors without updated economic justification for the deal.

Insights

TL;DR: Procedural 8-K: merger timetable intact; shareholder vote on 28 Jun 2025 remains key hurdle amid stated legal and integration risks.

The filing is chiefly administrative, serving to remind SunLink investors to cast their proxies on the Regional Health combination. Distribution of the Form S-4 and joint proxy statement indicates regulatory progress, but completion still depends on majority approvals and satisfaction of NYSE American and OTCQB listing standards. The expansive risk section鈥攍itigation exposure, integration complexity, revenue synergies, and macro factors鈥攈ighlights substantial execution uncertainty. With no new valuation data or revised terms, the disclosure is neutral for deal odds but signals management鈥檚 commitment to move the transaction forward on schedule.

SunLink Health Systems, Inc. (NYSE American: SSY) ha presentato un 8-K (Voce 8.01) datato 24 luglio 2025, comunicando il rilascio di un annuncio stampa relativo alla sua fusione in corso con Regional Health Properties, Inc.

  • Data di registrazione: 20 giugno 2025; gli azionisti sono invitati a inviare i propri voti per delega entro e non oltre il 28 giugno 2025, ore 23:59 EDT.
  • Regional ha gi脿 presentato un Modulo S-4 contenente la dichiarazione congiunta per delega/prospetto, spedito intorno al 30 giugno 2025.
  • Il comunicato stampa 猫 fornito come Allegato 99.1; un file di copertura Inline XBRL 猫 disponibile come Allegato 104.
  • La comunicazione ribadisce che non si tratta di un'offerta di vendita di titoli e invita gli investitori a ottenere copie gratuite dei materiali per delega tramite i siti web della SEC o della societ脿.

Il resto del rapporto 猫 costituito da disclaimer sulle dichiarazioni previsionali che evidenziano rischi quali possibili contenziosi, difficolt脿 di integrazione, conformit脿 ai requisiti di quotazione e condizioni macroeconomiche avverse. Non sono inclusi bilanci n茅 risultati operativi.

SunLink Health Systems, Inc. (NYSE American: SSY) present贸 un 8-K (Art铆culo 8.01) fechado el 24 de julio de 2025, informando sobre la publicaci贸n de un comunicado de prensa relacionado con su fusi贸n pendiente con Regional Health Properties, Inc.

  • Fecha de registro: 20 de junio de 2025; se insta a los accionistas a enviar sus votos por poder a m谩s tardar el 28 de junio de 2025, 11:59 p.m. EDT.
  • Regional ya ha presentado un Formulario S-4 que contiene la declaraci贸n conjunta para poderes/prospecto, enviado alrededor del 30 de junio de 2025.
  • El comunicado de prensa se presenta como Exhibici贸n 99.1; un archivo de portada Inline XBRL se proporciona como Exhibici贸n 104.
  • La presentaci贸n reitera que no es una oferta para vender valores y dirige a los inversores a obtener copias gratuitas de los materiales de poder a trav茅s de los sitios web de la SEC o de la empresa.

El resto del informe consiste en disclaimers sobre declaraciones prospectivas que describen riesgos tales como posibles litigios, dificultades de integraci贸n, cumplimiento de requisitos de listado y vientos macroecon贸micos adversos. No se incluyen estados financieros ni resultados operativos.

SunLink Health Systems, Inc. (NYSE American: SSY)電� 2025雲� 7鞗� 24鞚检瀽 8-K (頃 8.01)毳� 鞝滌稖頃橃棳 Regional Health Properties, Inc.鞕�鞚� 歆勴枆 欷戩澑 頃╇硲瓿� 甏�霠悳 氤措弰鞛愲 氚滍憸毳� 氤搓碃頄堨姷雼堧嫟.

  • 旮半鞚�: 2025雲� 6鞗� 20鞚�; 欤检＜霌れ潃 電柎霃� 2025雲� 6鞗� 28鞚� 鞓ろ泟 11:59 EDT旯岇 雽�毽� 韴憸毳� 鞝滌稖頃� 瓴冹潉 甓岅碃氚涭晿鞀惦媹雼�.
  • Regional鞚� 鞚措 瓿惦彊 鞙勳瀯鞛�/靹る獏靹滉皜 韽暔霅� Form S-4毳� 鞝滌稖頄堨溂氅�, 鞚措姅 2025雲� 6鞗� 30鞚缄步 鞖绊幐 氚滌啞霅橃棃鞀惦媹雼�.
  • 氤措弰鞛愲电� Exhibit 99.1搿� 鞝滉车霅橂┌, 鞚鸽澕鞚� XBRL 旎る矂 韺岇澕鞚� Exhibit 104搿� 鞝滉车霅╇媹雼�.
  • 頃措嫻 鞝滌稖 靹滊電� 歃濌秾 韺愲Г 鞝滌晥鞚� 鞎勲嫎鞚� 鞛皑 氇呾嫓頃橂┌, 韴瀽鞛愲摛鞐愱矊 SEC 霕愲姅 須岇偓 鞗轨偓鞚错姼毳� 韱淀暣 鞙勳瀯鞛� 鞛愲毳� 氍措搿� 氚涭潉 瓴冹潉 鞎堧偞頃╇媹雼�.

氤搓碃靹滌潣 雮橂ǜ歆� 攵�攵勳潃 鞛犾灛鞝� 靻岇啞, 韱淀暕 氍胳牅, 靸侅灔 鞖旉贝 欷�靾�, 瓯办嫓瓴届牅 鞐拲 霌� 鞙勴棙鞚� 靹る獏頃橂姅 氙鸽灅 鞓堨浮 歆勳垹 氅挫眳 臁绊暛鞙茧 甑劚霅橃柎 鞛堨姷雼堧嫟. 鞛鞝滍憸雮� 鞖挫榿 瓴瓣臣電� 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟.

SunLink Health Systems, Inc. (NYSE American聽: SSY) a d茅pos茅 un 8-K (Article 8.01) dat茅 du 24 juillet 2025, annon莽ant la publication d'un communiqu茅 de presse li茅 脿 sa fusion en attente avec Regional Health Properties, Inc.

  • Date d'enregistrement聽: 20 juin 2025聽; les actionnaires sont invit茅s 脿 soumettre leurs votes par procuration au plus tard le 28 juin 2025, 23h59 EDT.
  • Regional a d茅j脿 d茅pos茅 un Formulaire S-4 contenant la d茅claration de procuration/prospectus conjoint, envoy茅 vers le 30 juin 2025.
  • Le communiqu茅 de presse est fourni en tant que Pi猫ce 99.1聽; un fichier de couverture Inline XBRL est fourni en pi猫ce 104.
  • Le d茅p么t r茅it猫re qu'il ne s'agit pas d'une offre de vente de titres et invite les investisseurs 脿 obtenir gratuitement les documents de procuration via les sites web de la SEC ou de la soci茅t茅.

Le reste du rapport comprend des clauses de non-responsabilit茅 relatives aux d茅clarations prospectives, exposant des risques tels que des litiges potentiels, des difficult茅s d'int茅gration, la conformit茅 aux exigences de cotation et des vents contraires macro茅conomiques. Aucun 茅tat financier ni r茅sultat op茅rationnel n'est inclus.

SunLink Health Systems, Inc. (NYSE American: SSY) reichte am 24. Juli 2025 ein 8-K (Punkt 8.01) ein, in dem die Ver枚ffentlichung einer Pressemitteilung im Zusammenhang mit der anh盲ngigen Fusion mit Regional Health Properties, Inc. gemeldet wurde.

  • Stichtag: 20. Juni 2025; Aktion盲re werden aufgefordert, ihre Stimmrechtsvollmachten sp盲testens bis zum 28. Juni 2025, 23:59 Uhr EDT einzureichen.
  • Regional hat bereits ein Formular S-4 eingereicht, das die gemeinsame Vollmachts-/Prospekterkl盲rung enth盲lt, die etwa am 30. Juni 2025 versandt wurde.
  • Die Pressemitteilung ist als Anlage 99.1 beigef眉gt; eine Inline-XBRL-Coverdatei ist als Anlage 104 verf眉gbar.
  • Die Einreichung betont, dass es sich nicht um ein Angebot zum Verkauf von Wertpapieren handelt und verweist Investoren darauf, kostenlose Kopien der Vollmachtsunterlagen 眉ber die SEC- oder Unternehmenswebsites zu beziehen.

Der Rest des Berichts besteht aus Haftungsausschl眉ssen zu zukunftsgerichteten Aussagen, die Risiken wie m枚gliche Rechtsstreitigkeiten, Integrationsprobleme, Einhaltung von B枚rsenzulassungsanforderungen und makro枚konomische Gegenwinde darlegen. Es sind keine Finanzberichte oder Betriebsergebnisse enthalten.

false --12-31 0001981535 0001981535 2025-07-24 2025-07-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

 

Date of Report (date of earliest event reported): July 24, 2025

 

SHARPLINK GAMING, INC.

(Exact name of registrant as specified in charter)

 

Delaware   001-41962   87-4752260

(State of

Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

333 Washington Avenue North, Suite 104

Minneapolis, Minnesota 55402

(Address of Principal Executive Offices) (Zip Code)

 

612-293-0619

(Registrant’s Telephone Number, Including Area Code)

 

 

(Former Name or Former Address, is Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 per share   SBET   The Nasdaq Stock Market, LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Directors; Compensatory Arrangements of Certain Officers.

 

At the Special Meeting (as defined below) of SharpLink Gaming, Inc. (the “Company”), stockholders approved an amendment and restatement of the Company’s 2023 Equity Incentive Plan (as amended and restated, the “Amended and Restated Equity Incentive Plan”) to increase the number of shares of common stock reserved for issuance thereunder by 8,000,000 shares to 8,034,166 shares.

 

The foregoing description of the Amended and Restated Equity Incentive Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended and Restated Equity Incentive Plan, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K (the “Current Report”) and incorporated herein by reference.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On July 22, 2025, the Company filed a Second Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock, par value $0.0001 per share, from 100,000,000 to 500,000,000 and to make a corresponding change to the number of authorized shares of capital stock (the “Authorized Share Increase”). The Authorized Share Increase was approved by stockholders at the Special Meeting as described in Item 5.07 below and the Certificate of Amendment, including the Authorized Share Increase, became effective at 5:10 p.m. Eastern Time on July 24, 2025.

 

The foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report and incorporated herein by reference.

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On July 24, 2025, the Company convened a special meeting of stockholders (the “Special Meeting”) virtually via live webcast. Only stockholders of record at the close of business on June 18, 2025, the record date for the Special Meeting, were entitled to vote at the Special Meeting. As of the record date, 62,125,336 shares of the Company’s common stock were outstanding and entitled to vote at the Special Meeting. Based on the estimated preliminary voting results present at the meeting or by proxy were holders of 35,076,578 shares of the Company’s common stock, which represented approximately 56% of the voting power of all shares of common stock as of the record date and constituted a quorum for the transaction of business at the Special Meeting.

 

The stockholders of the Company voted on the following two proposals at the Special Meeting:

 

  1. To adopt an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock of the Company; and
     
  2. To adopt the Amended and Restated Equity Incentive Plan.

 

The estimated preliminary results of each proposal were as follows:

 

Proposal No. 1 – Approval of an Amendment to the Company’s Amended and Restated Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock.

 

For   Against   Abstain   Broker Non-Votes
34,643,535   405,830   27,213   –

 

Based on the votes set forth above, the stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock.

 

Proposal No. 2 – Approval of the Amended and Restated Equity Incentive Plan.

 

For   Against   Abstain   Broker Non-Votes
19,085,322   186,899   1,154,249   14,650,108

 

Based on the votes set forth above, the stockholders approved the Amended and Restated Equity Incentive Plan.

 

The Company plans to file an amendment to this Current Report with final numbers when available.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
Number		   Description
3.1   Second Certificate of Amendment to the Amended and Restated Certificate of Incorporation of SharpLink Gaming, Inc., effective as of July 24, 2025.
10.1   Amended and Restated Equity Incentive Plan.
104   Cover Page Interactive Data File (formatted as inline XBRL).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SHARPLINK GAMING, INC.
   
  By: /s/ Rob Phythian
  Name: Rob Phythian
  Title: Chief Executive Officer
Dated: July 25, 2025  

 

 

 

 

Source:

FAQ

When must SSY shareholders vote on the Regional Health merger?

Proxy votes are requested by 28 June 2025, 11:59 p.m. EDT.

What is the record date for SunLink鈥檚 merger vote?

Only holders of record as of 20 June 2025 are entitled to vote.

Where can investors access the joint proxy statement/prospectus for SSY?

Free copies are available on the SEC鈥檚 EDGAR system and on SunLink鈥檚 and Regional鈥檚 investor-relations webpages.

Which exhibit in the 8-K contains the related press release?

The press release is filed as Exhibit 99.1.

Does the 8-K include any new financial results for SunLink?

No. The filing contains no financial statements or earnings data; it is limited to merger-related voting information.
Stock SBET logo
Sharplink Gaming Ltd

NASDAQ:SBET

SBET Rankings

#11212 Ranked by Market Cap
N/A Ranked by Dividends

SBET Latest News

Jul 25, 2025
SharpLink Welcomes BlackRock Digital Assets Pioneer Joseph Chalom as Newly Appointed Co-CEO
Jul 22, 2025
SharpLink鈥檚 ETH Holdings Increase to 360,807 as of July, 20, 2025; Generated 567 ETH in Staking Rewards Since Treasury Strategy Launch on June 2, 2025
Jul 16, 2025
Bybit Lists SBET, CLSK and BITF, Bringing New TradFi Opportunities to Platform Users
Jul 15, 2025
SharpLink Becomes World鈥檚 Largest Corporate Holder of ETH, Reaching 280,706 as of July 13, 2025; Raises Additional $413 Million From July 7-11, 2025
Jul 11, 2025
SharpLink Gaming Completes Direct Purchase of 10,000 ETH from The Ethereum Foundation

SBET Latest SEC Filings

Jul 25, 2025
[8-K] SharpLink Gaming Ltd. Reports Material Event
Jul 22, 2025
[8-K] SharpLink Gaming Ltd. Reports Material Event
Jul 21, 2025
[Form 4/A] SharpLink Gaming Ltd. Amended Insider Trading Activity
Jul 21, 2025
[Form 4/A] SharpLink Gaming Ltd. Amended Insider Trading Activity
Jul 21, 2025
[Form 4/A] SharpLink Gaming Ltd. Amended Insider Trading Activity

SBET Stock Data

2.58B
98.30M
8.6%
4.79%
0.98%
Gambling
Services-prepackaged Software
United States
MINNEAPOLIS